Journal Guide

Die Fachzeitschrift NOTARZT wendet sich an Notärztinnen und Notärzte aus allen Fachgebieten – ob Anästhesiologie, Innere Medizin, Chirurgie, Unfallchirurgie, Neurologie, Pädiatrie oder Allgemeinmedizin. Sie ist Ihr Ratgeber in allen notfallmedizinischen, organisatorischen, rechtlichen und berufspolitischen Fragen. Hier finden Sie Notfallmedizin auf den Punkt gebracht: wissenschaftlich fundiert und interessant aufbereitet. Sie erhalten praxisorientierte Tipps zur optimalen prähospitalen Versorgung sowie zum Transport von Notfallpatienten.

Une revue d'actualitéAux confins de la neurologie, de la psychiatrie et de la gériatrie, NPGpropose à tous les acteurs de la prise en charge du vieillissement cérébral normal et pathologique, des développements récents et adaptés à leur pratique clinique.Un support de formation médicale continueNPG répond aux problématiques soulevées dans votre exercice quotidien au travers de nombreuses rubriques de FMC : Dossier thématique, Synthèse, Réflexions et perspectives, Pratique thérapeutique, Cas cliniques.Une approche pluridisciplinaireRésolument pluridisciplinaire, NPG rapporte le point de vue du neurologue, du psychiatre et du gériatre sur les grandes questions cliniques concernant le vieillissement cérébral.

Nano Today is the international journal for researchers with interests across the whole of nanoscience and technology. Through its unique mixture of peer-reviewed articles, the latest research news, and information on key developments, Nano Today provides comprehensive coverage of this exciting and dynamic new field.Description:Nano Today publishes original articles on all aspects of nanoscience and nanotechnology. Manuscripts of three types are considered: Review Articles that inform readers of the latest research and advances in nanoscience and nanotechnology, Rapid Communications that feature exciting research breakthroughs in the field, and News and Opinions that comment on topical issues or express views on the developments in related fields.Contributions include a variety of topics such as:• Synthesis and Self-Assembly of Nanostructured Materials and Films• Functionalization and Size-Dependent Properties of Nanocrystals, Quantum Dots and Nanowires• Processing and Templating of Nanotubes and Nanoporous Materials• Tailoring of Polymeric Nanoparticles, Organic-Inorganic Nanocomposites and Biohybrids• Fabrication of Nano and Micro Electro Mechanical Systems• Design and Engineering of Structural and Functional Nanomaterials• Nanosystems for Biological, Medical, Chemical, Catalytic, Energy and Environmental Applications• Nanodevices for Electronic, Photonic, Magnetic, Imaging, Diagnostic and Sensor Applications

• Human Nanotoxicology - nano-bio interactions and effects on human health;
• Econanotoxicology - nano-bio interactions and effects on organism and ecosystem health;
• Exposure - nanomaterial release, fate and behavior in the environment and human/engineered systems;
• Risk Assessment and Life Cycle Assessment

Other areas, such as the development of methodological and modelling approaches and the development of materials and methods to enhance nanosafety, are appropriate if there is a clear and demonstrable link to the above themes.

Types of article NanoImpact publishes the following article types:

• Original Research Articles: Demonstrate important new discoveries in the relevant fields;
• Critical Reviews: Comprehensively summarize and evaluate the latest developments in the relevant field;
• Frontiers: Identify potential new important areas in the relevant field.

Original Research Articles and Critical Reviews are limited to 7000 and 10000 words excluding figures, tables and references. A maximum of 6 figures/tables are allowed for research and review articles. Frontiers are limited to 2000 words, with up to an additional 3 figures and tables allowed. References are not included in this word limit. Longer articles can be considered if authors can provide a compelling argument in the cover letter. Editors will make the final decision.

Nanomedicine provides a unique medical-focused forum to address the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. The nanomedicine field is still in its infancy, however, in the next few years there will be further exciting developments in engineering, chemistry, physics and medical science, with researchers working together under the nanomedicine umbrella. Nanomedicine will provide a critical overview of these advances and their potential in preventing, diagnosing and treating human diseases, helping to shape the future of medicine in this exciting era.

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases. In addition to bimonthly issues, the journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories. The journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

Nanoscale is a high-impact international journal, publishing high-quality research across nanoscience and nanotechnology. Nanoscale publishes a full mix of research articles and reviews on experimental and theoretical work and is highly interdisciplinary, covering nanoscience, nanotechnology, quantum materials, quantum technology, physics, chemistry, biology, medicine, materials, energy/environment, information technology, detection science, healthcare, drug discovery, and electronics. Topics covered in the journal include, but are not limited to: synthesis of nanostructured and nanoscale materials; quantum materials; 2D materials; layered materials; characterisation of functional nanoscale materials and bio-assemblies; properties of nanoscale materials; self-assembly and molecular organisation; complex hybrid nanostructures; nanocomposites, nanoparticles, nanocrystalline materials, and nanoclusters; nanotubes, nanowires and nanocrystals; molecular nanoscience; nanocatalysis; theoretical modelling; single-molecules; plasmonics; nanoelectronics and molecular electronics; nanophotonics; nanochips, nanosensors, nanofluidics and nanofabrication; carbon-based nanoscale materials and devices; biomimetic materials; nanobiotechnology and bionanomaterials; nanomedicine; regulatory approaches and risk assessment.

Nanoscale Advances is an international gold open access journal, publishing high-quality research across the breadth of nanoscience and nanotechnology. The journal accepts experimental and theoretical work in the form of communications, full papers and reviews, building on and complementing the nano content already published across the Royal Society of Chemistry journal portfolio. Topics include, but are not limited to: synthesis of nanostructured and nanoscale materials; quantum materials; 2D materials; layered materials; layered quantum materials; characterisation of functional nanoscale materials and bio-assemblies; properties of nanoscale materials; self-assembly and molecular organisation; complex hybrid nanostructures; nanocomposites, nanoparticles, nanocrystalline materials, and nanoclusters; nanotubes, molecular nanowires and nanocrystals; molecular nanoscience; nanocatalysis; theoretical modelling; single-molecules; plasmonics; Nanoelectronics and molecular electronics; nanophotonics; nanochips, nanosensors, nanofluidics and nanofabrication; carbon-based nanoscale materials and devices; biomimetic materials; nanobiotechnology/bionanomaterials; nanomedicine; regulatory approaches and risk assessment

Nanoscale Horizons is a leading journal for the publication of exceptionally high-quality, innovative nanoscience and nanotechnology. The journal places an emphasis on original nano research that demonstrates a new concept or a new way of thinking (a conceptual advance), rather than primarily reporting technological improvements. However, outstanding articles featuring truly breakthrough developments such as record performance alone may also be published in the journal. Topics covered in the journal include, but are not limited to: synthesis of nanostructured and nanoscale materials; quantum materials; 2D materials; layered materials; characterisation of functional nanoscale materials and bio-assemblies; properties of nanoscale materials; self-assembly and molecular organisation; complex hybrid nanostructures; nanocomposites, nanoparticles, nanocrystalline materials, and nanoclusters; nanotubes, nanowires and nanocrystals; molecular nanoscience; nanocatalysis; theoretical modelling; single-molecules; plasmonics; nanoelectronics and molecular electronics; nanophotonics; nanochips, nanosensors, nanofluidics and nanofabrication; carbon-based nanoscale materials and devices; biomimetic materials; nanobiotechnology and bionanomaterials; nanomedicine; regulatory approaches and risk assessment.

The National Medical Journal of India is a premier bi-monthly health sciences journal published from India. It is widely indexed and abstracted in all the major abstracting services including Index Medicus (MEDLINE), Current Contents—Clinical Medicine, Excerpta Medica and BIOSIS. It is also indexed in the Science Citation Index.The Journal informs, educates and entertains through its myriad columns including Editorials, Selected summaries, Review articles, Original articles, letters from Chennai, Mumbai, Australia, North America and Glasgow, Book reviews, Clinico-pathological conferences, Everyday practice, Masala and News from Here and There. It provides for analysis and advocacy of issues relevant to health policy and health provider training through sections on ‘Medicine and society’ and ‘Medical education’. It also gives opportunity for expression of individual opinions on healthcare through its column ‘Speaking for myself’. .

Launched in January 2017, Nature Biomedical Engineering publishes original research, reviews and commentary of high significance to the biomedical engineering community, including bench scientists interested in devising materials, methods, technologies or therapies to understand or combat disease; engineers designing or optimizing medical devices and procedures; and clinicians leveraging research outputs in biomedical engineering to assess patient health or deliver therapy across a variety of clinical settings and healthcare contexts.

Like all Nature-branded journals, Nature Biomedical Engineering is run by a dedicated team of professional editors, and provides fair and rigorous peer review, high standards of copy-editing and production, swift publication and editorial independence.

Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. Priority is given to work that provides fundamental insight into the workings of the immune system. Areas covered include, but are not limited to, innate immunity and inflammation; development; immune receptors, signaling and apoptosis; antigen presentation; gene regulation and recombination; cellular and systemic immunity; vaccines; immune tolerance; autoimmunity and tumor immunology, microbial immunopathology; and transplantation.Nature Immunology places its highest priority on fair and rapid review and speedy publication. Decisions on whether to send a manuscript out for peer review are normally made within two working days of receipt and decisions about publication are typically made within two days of receipt of the referees' reports.In addition to publishing significant original research, Nature Immunology also publishes commentary, News and Views, brief research notes, historical perspectives, correspondence from readers and reviews of the literature, thus serving as the major conduit of top-quality information for the immunology community.

Nature Medicine is a biomedical research journal devoted to publishing the latest and most exciting advances in biomedical research for scientists and physicians, with an emphasis on clarity of presentation. Articles cover fields such as cancer biology, cardiovascular research, gene therapy, immunology, vaccine development, and neuroscience, aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings. Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation, and are submitted from research groups at universities, independent research institutions, and biotechnology and pharmaceutical industries world-wide. As a cross-disciplinary journal at the heart of the international biomedical research community, Nature Medicine publishes the most relevant original research articles, news, and commentary that form the foundations of tomorrow's medicine.

We are interested in the best research from across the field of microbiology, with our broad scope ensuring that the work published reaches the widest possible audience.

The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers carcinogenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and invasiveness. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer will be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.Subjects covered * Genomic instability: chromosomal and microsatellite instabilities; defects in DNA repair pathways. * Growth factor signalling to cell cycle progression: proto-oncogenes and their dysregulation. * Growth inhibitory signals: dysregulation of quiescence and differentiation, tumour suppressors and their inactivation. * Cellular immortality and telomere maintenance. * Cell death: evading apoptosis, including avoidance of immune surveillance systems. * Angiogenesis: sustaining tumour growth by building a vascular system. * Metastasis: moving to and surviving in new environments. * Carcinogenesis and cancer prevention: epidemiology, genetic and environmental triggers, gene–environment interactions and strategies for reducing risk. * Cancer diagnosis and prognosis: molecular markers; diagnostic imaging; defining tumour margins; detecting minimal residual disease. * New approaches to cancer therapy: rational drug design, gene therapy, immunotherapy, combination therapies, combating drug resistance and targeting therapies to the individual. * Experimental systems and techniques: cell culture and animal models, genomic and proteomic approaches to studying cancer. * Cancer-associated disease: cancer pain, cachexia, symptoms associated with treatment (hair loss, anaemia, gastrointestinal disease), psychosocial aspects of cancer. * Ethical, legal and social issues surrounding cancer research: trial design, genetic screening, public and professional education, research policy and advocacy. * Conventional approaches to cancer diagnosis and treatment: how do they perform, what are their drawbacks and how might they be improved in the future?.